• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Wiki Measure #251 HER2

Create Wiki
M

marybrady1

Contributor
Messages
10
Location
Harrisburg, PA
Best answers
0
Hi all. I'm looking for clarification on measure #251 for the breast receptors. It's my understanding 3394F and/or 3395F can either be added if both the HER2 and the estrogen/progesterone receptors are evaluated. If only the HER2 is evaluated is it sufficient to add 3394F to meet the measure? Or if just the non-HER2 is evaluated, is 3395F sufficient to meet the measure? I've read the guidelines and I think one or the other is acceptable. And both measures can be used if both evaluations are done. Thanks in advance!!!!
 
For #251: Performance Met (3394f) = having reported HER2 by IHC; so i.e. in our practice, when we are reporting the 88361 code for HER2 by IHC. Typically, when the HER2 by IHC is being run, we're also getting results for ER/PR but I don't see the point of using the 3395f (denominator exclusion) in addition to 3394f.
We will report 3395f (denominator exclusion) on the cases where only ER/PR testing is done (no HER2 by IHC). Hope this makes sense.

This resource has a nice flow chart included.
https://pqrsregistry.clinicspectrum.com/2016/individual_measures/251.pdf
 
You must log in or register to reply here.
Top